No profile data available.
Aardvark Therapeutics, Inc. (AARD) is a healthcare company in the obesity treatment pharmaceuticals industry, based in San Diego, United States, with about 28 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$57.59 million. Its market capitalization was $104.17 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
Aardvark Therapeutics reported $0 in revenue for fiscal year 2025.
$104.17 million as of October 9, 2026.
Listed companies of a similar size in the same industry (obesity treatment pharmaceuticals) include Rhythm Pharmaceuticals, Inc. (RYTM), Structure Therapeutics Inc. (GPCR), BioAge Labs, Inc. (BIOA), Skye Bioscience, Inc. (SKYE).